QID 317371

Date Published: 2023-10-17

QID 317371: Cisco IOx Application Hosting Environment Privilege Escalation Vulnerability (cisco-sa-rdocker-uATbukKn)

A vulnerability in the on-device application development workflow feature for the Cisco IOx application hosting infrastructure in Cisco IOS XE Software could allow an authenticated, remote attacker to access the underlying operating system as the root user.

Affected Products
Catalyst IE3x00 Rugged Series Switches
Catalyst IR1100 Rugged Series Routers
Catalyst IR1800 Rugged Series Routers
Catalyst IR8100 Heavy Duty Series Routers
Catalyst IR8300 Rugged Series Routers
Embedded Services 3300 Series Switches
Note: This QID does not check for the Application Development Workflow

QID Detection Logic (Authenticated):
The check matches Cisco IOS XE version retrieved via Unix Auth using "show version" command.
QID Detection Logic (Unauthenticated):
The check matches Cisco IOS XE version retrieved via SNMP or TCP/IP Fingerprint or NTP or Telnet.

An attacker could exploit this vulnerability by using the Docker CLI to access an affected device.

  • CVSS V3 rated as Critical - 8.8 severity.
  • CVSS V2 rated as High - 7.7 severity.
    • Solution

    Customers are advised to refer to cisco-sa-rdocker-uATbukKn for more information.

    Vendor References

    CVEs related to QID 317371

    CVE-2023-20235 |
    Software Advisories
    Advisory ID Software Component Link
    cisco-sa-rdocker-uATbukKn URL Logo sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-rdocker-uATbukKn
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].